Meier, C.; La Rocca, G.; Nawrot, V.; Fißlthaler, B.; Overby, S.J.; Hourfar, K.; Plotz, G.; Seidl, C.; Ziegler, P.; Wild, P.;
et al. Erk Inhibition as a Promising Therapeutic Strategy for High IL-8-Secreting and Low SPTAN1-Expressing Colorectal Cancer. Int. J. Mol. Sci. 2024, 25, 5658.
https://doi.org/10.3390/ijms25115658
AMA Style
Meier C, La Rocca G, Nawrot V, Fißlthaler B, Overby SJ, Hourfar K, Plotz G, Seidl C, Ziegler P, Wild P,
et al. Erk Inhibition as a Promising Therapeutic Strategy for High IL-8-Secreting and Low SPTAN1-Expressing Colorectal Cancer. International Journal of Molecular Sciences. 2024; 25(11):5658.
https://doi.org/10.3390/ijms25115658
Chicago/Turabian Style
Meier, Clara, Gianluca La Rocca, Virginia Nawrot, Beate Fißlthaler, Sarah J. Overby, Kai Hourfar, Guido Plotz, Christian Seidl, Paul Ziegler, Peter Wild,
and et al. 2024. "Erk Inhibition as a Promising Therapeutic Strategy for High IL-8-Secreting and Low SPTAN1-Expressing Colorectal Cancer" International Journal of Molecular Sciences 25, no. 11: 5658.
https://doi.org/10.3390/ijms25115658
APA Style
Meier, C., La Rocca, G., Nawrot, V., Fißlthaler, B., Overby, S. J., Hourfar, K., Plotz, G., Seidl, C., Ziegler, P., Wild, P., Zeuzem, S., Brieger, J., Jäger, E., Battmann, A., & Brieger, A.
(2024). Erk Inhibition as a Promising Therapeutic Strategy for High IL-8-Secreting and Low SPTAN1-Expressing Colorectal Cancer. International Journal of Molecular Sciences, 25(11), 5658.
https://doi.org/10.3390/ijms25115658
